Great Basin Scientific (NASDAQ:GBSN) : During the past 4 weeks, traders have been relatively bearish on Great Basin Scientific (NASDAQ:GBSN), hence the stock is down -26.47% when compared to the S&P 500 during the same period. However, in the past 1 week, the selling of the stock is down by -20.28% relative to the S&P 500. The 4-week change in the price of the stock is -25.29% and the stock has fallen -19.26% in the past 1 week.
The company shares have dropped -99.98% from its 1 Year high price. On Jul 17, 2015, the shares registered one year high at $6,384.00 and the one year low was seen on Jul 8, 2016. The 50-Day Moving Average price is $1.83 and the 200 Day Moving Average price is recorded at $7.28.
The stock has recorded a 20-day Moving Average of 25.01% and the 50-Day Moving Average is 38.44%.
Great Basin Scientific (NASDAQ:GBSN): On Fridays trading session , Opening price of the stock was $1.43 with an intraday high of $1.43. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $1.27. However, the stock managed to close at $1.3, a loss of 9.09% for the day. On the previous day, the stock had closed at $1.43. The total traded volume of the day was 1,851,140 shares.
In an insider trading activity, Spafford David, director of Great Basin Scientific, Inc., executed a transaction worth $9,798 on August 21, 2015. A total of 6,665 shares were purchased at an average price of $1.47. The Insider information was divulged by the Securities and Exchange Commission in a Form 4 filing. The information is based on open market trades at the market prices.Option exercises are not covered.
Great Basin Scientific, Inc. is a molecular diagnostic testing company. The Company is focused on the development and commercialization of its molecular diagnostic platform designed to test for infectious disease. The Company has a commercially available test, a diagnostic test for clostridium difficile (C. diff), which received clearance from the Food and Drug Administration (FDA). The Companys products under development also include a diagnostic test for Group B Strep., Staphylococcus Identification and Resistance Blood Infection Panel (Staph ID/R panel), STEC Test, Staph aureus (SA) Pre-Surgical Nasal Screen Test, Food Borne Pathogens Panel and Candida Blood Infection Panel. The Companys platform is an automated molecular diagnostic system, consisting of an analyzer and associated diagnostic tests.